These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 9838907

  • 1. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
    Mizumatsu S, Matsumoto K, Maeda Y, Tamiya T, Furuta T, Ohmoto T.
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2055-60. PubMed ID: 9838907
    [Abstract] [Full Text] [Related]

  • 2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
    Levin VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK, Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW.
    Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
    [Abstract] [Full Text] [Related]

  • 6. [Preliminary results of a combination therapy of irradiation, MCNU, carboplatin (CBDCA) and IFN-beta (MCI therapy) for gliomas].
    Shinohara C, Matsumoto K, Nakagawa M, Ono Y, Higashi H, Tsuno K, Maeshiro T, Tamiya T, Furuta T, Ohmoto T.
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):2067-9. PubMed ID: 8215484
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Randomized study of initial treatment with radiation.MCNU or radiation.MCNU.interferon-beta for malignant glioma. Hiroshima Brain Tumor Study Group].
    Kiya K, Uozumi T, Kurisu K, Inagawa T, Ohta M, Kajikawa H, Kawashima K, Kitaoka T, Goishi A, Kodama Y.
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):221-6. PubMed ID: 2405777
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma.
    Yamamoto M, Iwaasa M, Nonaka M, Tsugu H, Nabeshima K, Fukushima T.
    Anticancer Res; 2005 Mar; 25(6A):3715-23. PubMed ID: 16302731
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical trial of MCNU for malignant brain tumors].
    Harada K, Okamoto H, Fujioka Y, Uozumi T, Kiya K, Kitaoka T, Goishi A, Sasaki U, Shima T, Inagawa T.
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
    [Abstract] [Full Text] [Related]

  • 17. [Synchronization chemoradiotherapy for malignant gliomas].
    Yamamoto H, Sato F, Nakamura O, Kohno T, Shitara N, Takakura K, Sano K, Maehara T, Akanuma A.
    No Shinkei Geka; 1984 Jun; 12(7):795-805. PubMed ID: 6592471
    [Abstract] [Full Text] [Related]

  • 18. [Effect of intra-arterial and local administration of MCNU on cerebral malignant gliomas].
    Watanabe M, Takeda N, Tanaka R.
    Gan To Kagaku Ryoho; 1995 May; 22(6):811-4. PubMed ID: 7755390
    [Abstract] [Full Text] [Related]

  • 19. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
    Reck M, von Pawel J, Macha HN, Kaukel E, Deppermann KM, Bonnet R, Ulm K, Hessler S, Gatzemeier U.
    Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013
    [Abstract] [Full Text] [Related]

  • 20. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA, Uhm JH, Jaeckle KA, Choucair A, Flynn PJ, Yung WKA, Prados MD, Bruner JM, Chang SM, Kyritsis AP, Gleason MJ, Hess KR.
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.